Drug advertising: Truths, half-truths and few statistics

Medical Journal of Australia

Volumn 177, Issue 6, 2002, Pages 285-286

  Newby, David A ^a   Henry, David A ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; DEXTROPROPOXYPHENE; PERIPHERAL VASODILATING AGENT; VASODILATOR AGENT;

DRUG CLASSIFICATION; DRUG COST; DRUG EFFICACY; DRUG INDUSTRY; DRUG INFORMATION; DRUG LEGISLATION; DRUG MARKETING; DRUG SAFETY; EDITORIAL; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HEALTH EDUCATION; INVESTMENT; MEDICAL LITERATURE; MEDICAL PRACTICE; OUTCOMES RESEARCH; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; RISK MANAGEMENT; STANDARD; STATISTICS;

EID: 0037120602     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2002.tb04782.x     Document Type: Editorial

References (9)

1. Loke TW, Koh FC, Ward JE. Pharmaceutical advertisement claims in Australian medical publications. Is evidence accessible, compelling and communicated comprehensively? Med J Aust 2002; 177: 291-293.
2. US Food and Drug Administration. Federal Food, Drug, and Cosmetic Act. Available at: .
3. Angell M. The pharmaceutical industry - To whom is it accountable? N Engl J Med 2000; 342: 1902-1904.
4. Association of Medical Publishers. The value of medical journal advertising. . Accessed 4 July 2002.
5. Neslin S. ROI analysis of pharmaceutical promotion: An independent study: Executive summary. 2001. . Accessed 4 July 2002.
6. Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med 1982; 73: 4-8.
7. Galbaly R. National competition review of drugs, poisons and controlled substances legislation. Canberra: Therapeutic Goods Administration, 2000. Available at: >http://www.health.gov.au/tga/docs/html/rdpdfr.htm>.
8. Watson J. EC moves towards "direct to consumer" advertising [news]. BMJ 2001; 323: 184.
9. Medicines Australia. Code of conduct. . Accessed 12 July 2002.